Phacilitate is a global platform serving the advanced therapies industry through events, content, research, networking and industry intelligence. We connect the people responsible for developing, manufacturing, funding, regulating and commercialising cell and gene therapies.

Phacilitate serves professionals across the advanced therapies ecosystem, including biotechnology companies, pharmaceutical organisations, investors, academics, regulators, healthcare providers, manufacturers, technology providers and patient-focused organisations.

Across all three events, gene therapy is a core focus. Sessions span clinical trials, molecular therapy innovations, CRISPR-based therapy, CAR T therapy, and the evolving regulatory landscape for gene therapies. You’ll also explore key themes such as patient access, platform scalability, and approaches to gene therapy research.

Advanced Therapies Europe - September 7-9, 2026 in Barcelona, Spain 

Advanced Therapies World - December 5-6, 2026 in Riyadh, Saudi Arabia 

Advanced Therapies Week - January 18-21, 2027 in San Diego, USA 

You’ll connect with global leaders across the cell and gene therapy ecosystem, including therapeutic developers, regulators, investors, CROs, CDMOs, academics, and patient advocates. Whether you’re seeking strategic partnerships or clinical collaborators, these events bring the right people together.

Expect to hear from CEOs of pioneering biotech companies, clinical leaders, regulators from the FDA and EMA, and research scientists shaping the future of gene therapy. Many are directly involved in recent gene therapy approvals or are breaking ground in next-gen platforms and clinical applications.

Yes, the show floor features companies specialising in clinical pharmacology, gene delivery technologies, manufacturing solutions, and platform innovation. You’ll find partners for every stage of your therapy’s development, from discovery through to commercialisation.

Our events offer focused tracks and roundtables built around key gene & cell therapy themes. Whether you’re looking to overcome delivery challenges, navigate regulatory hurdles, or engage with patients more effectively, you’ll find actionable insights grounded in real-world data and experience.

Absolutely. Dedicated programming supports emerging companies — from sessions on trial readiness and scale-up, to investor showcases and access to industry mentors. You’ll gain practical knowledge and meet people who understand the challenges of bringing a gene therapy to market.

Yes. Sessions include direct input from patient advocates, covering topics such as ethical trial design, informed consent, and real-world barriers to patient access. These perspectives are critical to ensuring that the therapies we develop are meaningful and accessible.

Yes. Events such as Advanced Therapies Europe offer CPD accreditation, supporting your continued growth in areas like clinical research, regulatory strategy, and innovation in gene therapy.

Advanced therapies are a group of innovative treatments that include cell therapies, gene therapies, regenerative medicine and tissue-engineered products. These therapies aim to address diseases at their source and have the potential to transform patient outcomes across oncology, rare disease, autoimmune conditions and many other therapeutic areas.

The industry faces a range of challenges, including clinical development, manufacturing scale-up, regulatory alignment, investment, reimbursement, patient access and commercialisation. Solving these challenges requires collaboration across the entire ecosystem.

Phacilitate supports the industry through global events, expert-led content, market insights, thought leadership, networking opportunities and industry partnerships designed to help organisations solve challenges and accelerate progress.

Phacilitate publishes industry content, expert interviews, research, event insights and thought leadership covering topics such as clinical development, manufacturing, regulation, investment, market access and emerging technologies in advanced therapies.

Phacilitate covers the full advanced therapies lifecycle, including cell therapy, gene therapy, regenerative medicine, clinical development, manufacturing, automation, regulation, investment, commercialisation, reimbursement, patient access and emerging technologies.

Many organisations build relationships through industry networks, events, strategic partnerships and thought leadership communities. Phacilitate helps facilitate these connections by bringing together stakeholders from across the advanced therapies ecosystem.

The future of cell and gene therapy is expected to be shaped by advances in manufacturing, automation, gene editing, AI-enabled development, regulatory innovation and new commercial models that improve patient access to transformative treatments.

Phacilitate meetings are designed to help advanced therapies professionals build meaningful connections and solve real business challenges. Rather than focusing solely on presentations, our events combine curated networking, facilitated introductions, interactive discussions and expert-led content to connect the people developing, manufacturing, funding, regulating and commercialising advanced therapies.

Phacilitate combines technology, curated introductions and facilitated networking to help attendees meet the people most relevant to their goals. Whether you're seeking investment, manufacturing partners, collaborators, customers or industry insight, our events are designed to make meaningful conversations easier to start and more valuable to continue.

This depends on which event you wish to attend. Simply, select the event or meeting you want to attend from the main website menu and you’ll find full details about tickets, pricing, and what’s included.

Look at the agenda, set up your partnering profile, and plan any meetings in advance. If you’re speaking or exhibiting, make sure your profile is filled in so people can find you.

Yes. You can book a stand, sponsor a session, join the speaker line-up, or get listed in the Cell and Gene Directory. It’s a great way to get in front of decision-makers. If you're interested in learning more, simply visit the main website page for the event/meeting you wish to attend, and navigate to the sponsorship tab from there. 

Use the sign up option on the home page to receive regular updates, which is positioned as the route to the latest news, programme updates, and releases. If you are coordinating attendance across a team, it can also help to subscribe early so you do not miss key milestones.